An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 10, 2014, Pages 1358-1364

  Tacha, David ^a   Bremer, Ryan ^a   Haas, Thomas ^b   Qi, Weiman ^a  

^a Departments of Research and Development   (United States)

^b Department of Pathology Mercy General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GLYCOPROTEIN 40 ANTIGEN, HUMAN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ADENOCARCINOMA; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; METABOLISM; PATHOLOGY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RABBIT; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; LUNG; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MICE, INBRED BALB C; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RABBITS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 84907679259     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0342-OA     Document Type: Article

References (20)

1. Nobre AR, Albergaria A, Schmitt F. p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63. Acta Cytol. 2013;57(1):1-8.
2. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8(2):494-501.
3. Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol. 2012;25(3):405-415.
4. Nonaka D. A study of ΔNp63 expression in lung non-small cell carcinomas. Am J Surg Pathol. 2012;36(6):895-899.
5. Pelosi G, Fabbri A, Bianchi F, et al. ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cell blocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. J Thorac Oncol. 2012;7(2):281-290.
6. Brown AF, Sirohi D, Fukuoka J, et al. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung. Arch Pathol Lab Med. 2013;137(9):1274-1281.
7. Yamaguchi K, Wu L, Caballero OL, et al. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer. 2000;86(5):684-689.
8. Karni-Schmidt O, Castillo-Martin M, Shen TH, et al. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression. Am J Pathol. 2011;178(3):1350-1360.
9. Sailer V, Stephan C, Wernert N, et al. Comparison of p40 (ΔNp63) and p63 expression in prostate tissues which one is the superior diagnostic marker for basal cells. Histopathology, 2013;63(1):50-56.
10. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol. 2001;25(8):1054-1060.
11. Hibi K, Trink B, Patturajan M, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A. 2000;97(10):5462-5467.
12. Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK. Frequent gain of the p40/p51/p63 gene locus in primary head in primary head and neck cancers. Int J Cancer. 2000;86(5):684-689.
13. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, et al. ΔNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res. 2009;15(19):6284-6291.
14. Dabir PD, Ottosen P, Hyer S, Hamilton-Dutoit S. Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma. Diagn Pathol. 2012;7:81. doi: 10.1186/1746-1596-7-81.
15. Jiang Z, Li C, Fischer A, Dresser K, Woda BA. Using an AMACR (P504S)/34bE12/ p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol. 2005;123(2):231-236.
16. Morita M, Uramoto H, Nakata S, et al. Expression of deltaNp63 in squamous cell carcinoma of the esophagus. Anticancer Res. 2005;25(5):3533-3539.
17. Lin Z, Liu M, Li Z, Kim C, Lee E, Kim I. ΔNp63 protein expression in uterine cervical and endometrial cancers. J Cancer Res Clin Oncol. 2006;132(12):811-816.
18. Dotto J, Pelosi G, Rosai J. Expression of p63 in thymomas and normal thymus. Am J Clin Pathol. 2007;127(3):415-420.
19. Rekhtman N, Tafe LJ, Chaft JE, et al. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Mod Pathol. 2013;26(4):511-522.
20. Barbareschi M, Cantaloni C, Del Vescovo V. Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis. Am J Clin Pathol. 2011;136(5):773-782.